BPG is committed to discovery and dissemination of knowledge
Featured Articles
Chronic hepatitis B virus infection in Eastern Ethiopia: Clinical characteristics and determinants of cirrhosis
Browse: 1   Download: 0   Issue Date: 2024-07-26
Improvement of hepatic fibrosis after tenofovir disoproxil fumarate switching to tenofovir alafenamide for three years
Browse: 2   Download: 0   Issue Date: 2024-07-26
Predictive value of serum alanine aminotransferase for fatty liver associated with metabolic dysfunction
Browse: 1   Download: 0   Issue Date: 2024-07-26
Interleukin-mediated therapies in liver diseases and comorbidity effects
Browse: 1   Download: 0   Issue Date: 2024-07-26
Roles of transforming growth factor-β signaling in liver disease
Browse: 1   Download: 0   Issue Date: 2024-07-26
Successful treatment of severe hepatic impairment in erythropoietic protoporphyria: A case report and review of literature
Browse: 86   Download: 131   Issue Date: 2024-06-27
Liver histological changes in untreated chronic hepatitis B patients in indeterminate phase
Browse: 76   Download: 158   Issue Date: 2024-06-27
Importance of the gut microbiota in the gut-liver axis in normal and liver disease
Browse: 80   Download: 96   Issue Date: 2024-06-27
Sarcopenia and metabolic dysfunction associated steatotic liver disease: Time to address both
Browse: 80   Download: 89   Issue Date: 2024-06-27
Immunological crossroads: The intriguing dance between hepatitis C and autoimmune hepatitis
Browse: 73   Download: 97   Issue Date: 2024-06-27
Ornithine aspartate effects on bacterial composition and metabolic pathways in a rat model of steatotic liver disease
Browse: 90   Download: 142   Issue Date: 2024-05-27
Current concepts in the management of non-cirrhotic non-malignant portal vein thrombosis
Browse: 64   Download: 105   Issue Date: 2024-05-27
Nano-revolution in hepatocellular carcinoma: A multidisciplinary odyssey - Are we there yet?
Browse: 62   Download: 88   Issue Date: 2024-05-27
Liver disease in patients with transfusion-dependent β-thalassemia: The emerging role of metabolism dysfunction-associated steatotic liver disease
Browse: 71   Download: 73   Issue Date: 2024-05-27
Hepatitis C virus eradication in people living with human immunodeficiency virus: Where are we now?
Browse: 69   Download: 93   Issue Date: 2024-05-27
Expression and clinical significance of short-chain fatty acids in patients with intrahepatic cholestasis of pregnancy
Browse: 73   Download: 197   Issue Date: 2024-04-27
Molecular mechanism of nanomaterials induced liver injury: A review
Browse: 84   Download: 119   Issue Date: 2024-04-27
Metabolic dysfunction-associated steatotic liver disease: A silent pandemic
Browse: 83   Download: 110   Issue Date: 2024-04-27
Subclinical hepatitis E virus genotype 1 infection: The concept of “dynamic human reservoir”
Browse: 79   Download: 141   Issue Date: 2024-04-27
Progress of mitochondrial and endoplasmic reticulum-associated signaling and its regulation of chronic liver disease by Chinese medicine
Browse: 65   Download: 116   Issue Date: 2024-04-27